NCT03977870View on ClinicalTrials.gov

Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome Analysis

CompletedOBSERVATIONAL

Enrollment

843

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

May 13, 2019

Study Completion Date

August 3, 2023

Conditions

Venous Thromboembolism (VTE)

Interventions

OTHER

vital status determination

consultation of national registries

Trial Locations (1)

13005

Assistance Publique Hôpitaux de Marseille, Marseille

All Listed Sponsors

lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT03977870 - Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome Analysis | Biotech Hunter | Biotech Hunter